Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Utilisation Study of Intuniv® (Guanfacine Extended Release) in European Countries

NCT05870605 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT05870605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Utilisation Study of Intuniv® (Guanfacine Extended Release) in European Countries
Lead sponsor
Shire
Phase
Observational
Overall status
Completed
Start date
November 15, 2018
Completion date
April 30, 2022
Enrollment
5,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder (adhd)